Aviva’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.6M | Buy |
459,623
+20,762
| +5% | +$1.74M | 0.06% | 276 |
|
|
2026
Q1 | $35.1M | Sell |
438,861
-51,838
| -11% | -$4.27M | 0.06% | 290 |
|
|
2025
Q4 | $41.8M | Buy |
490,699
+25,427
| +5% | +$2.09M | 0.07% | 253 |
|
|
2025
Q3 | $36.2M | Buy |
465,272
+27,630
| +6% | +$2.16M | 0.07% | 272 |
|
|
2025
Q2 | $34.2M | Sell |
437,642
-468,645
| -52% | -$35M | 0.07% | 260 |
|
|
2025
Q1 | $65.7M | Buy |
906,287
+108,372
| +14% | +$7.76M | 0.16% | 141 |
|
|
2024
Q4 | $59.1M | Buy |
797,915
+20,073
| +3% | +$1.4M | 0.15% | 138 |
|
|
2024
Q3 | $51.3M | Buy |
777,842
+212,495
| +38% | +$15.4M | 0.13% | 183 |
|
|
2024
Q2 | $52.2M | Buy |
565,347
+173,003
| +44% | +$15.3M | 0.14% | 145 |
|
|
2024
Q1 | $37.5M | Sell |
392,344
-102,590
| -21% | -$8.62M | 0.12% | 199 |
|
|
2023
Q4 | $37.7M | Buy |
494,934
+61,951
| +14% | +$4.31M | 0.14% | 171 |
|
|
2023
Q3 | $30M | Buy |
432,983
+19,992
| +5% | +$1.61M | 0.13% | 189 |
|
|
2023
Q2 | $39M | Sell |
412,991
-6,634
| -2% | -$577K | 0.16% | 127 |
|
|
2023
Q1 | $34.7M | Buy |
419,625
+70,129
| +20% | +$5.51M | 0.16% | 165 |
|
|
2022
Q4 | $26.1M | Buy |
349,496
+54,585
| +19% | +$4.21M | 0.13% | 212 |
|
|
2022
Q3 | $24.4M | Sell |
294,911
-800
| -0.3% | -$77K | 0.14% | 185 |
|
|
2022
Q2 | $28.1M | Buy |
295,711
+13,343
| +5% | +$1.38M | 0.15% | 156 |
|
|
2022
Q1 | $33.2M | Sell |
282,368
-404,882
| -59% | -$45.4M | 0.17% | 122 |
|
|
2021
Q4 | $89M | Sell |
687,250
-53,096
| -7% | -$6.19M | 0.37% | 52 |
|
|
2021
Q3 | $83.8M | Buy |
740,346
+21,052
| +3% | +$2.4M | 0.37% | 54 |
|
|
2021
Q2 | $74.5M | Buy |
719,294
+14,181
| +2% | +$1.34M | 0.33% | 67 |
|
|
2021
Q1 | $59M | Buy |
705,113
+343
| +0% | +$29K | 0.29% | 82 |
|
|
2020
Q4 | $64.3M | Buy |
704,770
+21,086
| +3% | +$1.75M | 0.33% | 68 |
|
|
2020
Q3 | $54.6M | Buy |
683,684
+9,581
| +1% | +$748K | 0.32% | 73 |
|
|
2020
Q2 | $46.6M | Buy |
674,103
+3,258
| +0.5% | +$232K | 0.29% | 81 |
|
|
2020
Q1 | $42.2M | Buy |
670,845
+114,864
| +21% | +$8.28M | 0.31% | 73 |
|
|
2019
Q4 | $43.2M | Sell |
555,981
-45,141
| -8% | -$3.52M | 0.26% | 84 |
|
|
2019
Q3 | $44.1M | Buy |
601,122
+242,616
| +68% | +$17M | 0.3% | 79 |
|
|
2019
Q2 | $22.1M | Sell |
358,506
-5,994
| -2% | -$362K | 0.15% | 142 |
|
|
2019
Q1 | $23.2M | Sell |
364,500
-168,996
| -32% | -$9.64M | 0.16% | 137 |
|
|
2018
Q4 | $27.2M | Sell |
533,496
-56,988
| -10% | -$2.88M | 0.2% | 109 |
|
|
2018
Q3 | $34.3M | Sell |
590,484
-22,485
| -4% | -$1.1M | 0.19% | 121 |
|
|
2018
Q2 | $29.7M | Sell |
612,969
-7,785
| -1% | -$363K | 0.18% | 131 |
|
|
2018
Q1 | $28.9M | Sell |
620,754
-32,868
| -5% | -$1.43M | 0.18% | 128 |
|
|
2017
Q4 | $24.6M | Sell |
653,622
-37,893
| -5% | -$1.39M | 0.14% | 166 |
|
|
2017
Q3 | $25.2M | Buy |
691,515
+11,088
| +2% | +$423K | 0.14% | 173 |
|
|
2017
Q2 | $26.8M | Buy |
680,427
+4,860
| +0.7% | +$177K | 0.15% | 158 |
|
|
2017
Q1 | $21.2M | Sell |
675,567
-20,790
| -3% | -$651K | 0.12% | 184 |
|
|
2016
Q4 | $21.8M | Buy |
696,357
+304,062
| +78% | +$9.85M | 0.13% | 179 |
|
|
2016
Q3 | $15.8M | Buy |
392,295
+8,727
| +2% | +$329K | 0.1% | 241 |
|
|
2016
Q2 | $12.8M | Buy |
383,568
+55,293
| +17% | +$1.89M | 0.09% | 262 |
|
|
2016
Q1 | $9.65M | Buy |
328,275
+5,001
| +2% | +$138K | 0.07% | 303 |
|
|
2015
Q4 | $8.51M | Sell |
323,274
-1,146
| -0.4% | -$29.8K | 0.06% | 327 |
|
|
2015
Q3 | $7.69M | Sell |
324,420
-82,476
| -20% | -$1.99M | 0.06% | 333 |
|
|
2015
Q2 | $9.66M | Sell |
406,896
-20,358
| -5% | -$459K | 0.07% | 311 |
|
|
2015
Q1 | $10.1M | Buy |
427,254
+6
| +0% | +$135 | 0.07% | 326 |
|
|
2014
Q4 | $9.07M | Buy |
427,248
+5,442
| +1% | +$109K | 0.07% | 319 |
|
|
2014
Q3 | $7.18M | Sell |
421,806
-5,412
| -1% | -$85.4K | 0.06% | 376 |
|
|
2014
Q2 | $6.11M | Sell |
427,218
-2,958
| -0.7% | -$40.1K | 0.05% | 438 |
|
|
2014
Q1 | $5.32M | Sell |
430,176
-37,056
| -8% | -$428K | 0.04% | 447 |
|
|
2013
Q4 | $5.12M | Buy |
467,232
+10,338
| +2% | +$117K | 0.04% | 446 |
|
|
2013
Q3 | $5.3M | Buy |
456,894
+64,512
| +16% | +$755K | 0.05% | 396 |
|
|
2013
Q2 | $4.39M | Buy |
+392,382
| New | +$4.64M | 0.04% | 388 |
|
Other funds holding EW
Aviva's EW Position: Q2 2026 in Review
Aviva increased its Edwards Lifesciences (EW) stake by 4.7% in Q2 2026, buying an estimated $1.74M and bringing the position to 459,623 shares worth $41.6M. The position accounts for 0.06% of the portfolio, ranked #276.
Aviva first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $89M in Q4 2021. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Aviva held 459,623 shares of Edwards Lifesciences worth $41.6M as of Q2 2026.
- Aviva bought 20,762 Edwards Lifesciences shares in Q2 2026, an estimated $1.74M.
- Edwards Lifesciences made up 0.06% of Aviva's portfolio in Q2 2026, its #276 holding.
- Aviva first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Aviva's Edwards Lifesciences position peaked at $89M in Q4 2021.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.